1900 Wealth Management’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

1900 Wealth Management’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-180,555	Closed	-$1.91M	–	261
2023 Q1	$1.91M	Hold	180,555	–	–	0.21%	89
2022 Q4	$1.91M	Hold	180,555	–	–	0.21%	86
2022 Q3	$812K	Buy	180,555 +80,000	+80%	+$365K	0.1%	125
2022 Q2	$402K	Buy	100,555 +5,000	+5%	+$23.7K	0.04%	165
2022 Q1	$699K	Buy	95,555 +72,205	+309%	+$432K	0.07%	141
2021 Q4	$131K	Buy	23,350 +1,350	+6%	+$8.57K	0.01%	238
2021 Q3	$141K	Hold	22,000	–	–	0.01%	213
2021 Q2	$185K	Buy	+22,000	New	+$178K	0.02%	212

Other funds holding PRVB

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

1900 Wealth Management's PRVB Position: Q2 2023 in Review

1900 Wealth Management sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 180,555 shares — an estimated $1.91M sold.

1900 Wealth Management first reported a position in PRVB in Q2 2021 and held it in 8 quarters. The position peaked at $1.91M in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

1900 Wealth Management reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
1900 Wealth Management sold 180,555 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $1.91M.
1900 Wealth Management first reported a position in Provention Bio, Inc. Common Stock in Q2 2021 and held it in 8 quarters.
1900 Wealth Management's Provention Bio, Inc. Common Stock position peaked at $1.91M in Q1 2023.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on 1900 Wealth Management's 13F filing for Q2 2023, filed 21 Jul 2023.